<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01632735</url>
  </required_header>
  <id_info>
    <org_study_id>5K01DA027754-03</org_study_id>
    <secondary_id>1K01DA027754-01A1</secondary_id>
    <nct_id>NCT01632735</nct_id>
  </id_info>
  <brief_title>Mobile Continuing Care Approach for Youth</brief_title>
  <official_title>Mobile Continuing Care Approach for Youth</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azusa Pacific University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Azusa Pacific University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to test the effectiveness of a pilot mobile based
      continuing care program (monitoring/feedback texting) relative to standard continuing care as
      usual in reducing relapse and improving psychosocial functioning outcomes in a youth
      population (under 24) with substance abuse problems.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will include approximately 80 participants randomized to either 12 weeks of mobile
      continuing care (intervention) or standard continuing care as usual (control). Participants
      will be recruited from the treatment programs in Los Angeles County, including Matrix
      Institute on Addictions, Tarzana Treatment, Twin Town, Phoenix House, and Cri-Help. During
      the 12-week active program, participants will be monitored monthly via telephone data
      collection. Both groups will be followed for 10-months using repeated assessments
      (self-report and urine specimens) at baseline (month 0) and at follow-up points (months 3, 6,
      and 9).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Substance Use (Defined as Substance Received Treatment for)</measure>
    <time_frame>Baseline, discahrge, 3 month follow-up, 6 month follow-up, 9 month follow-up</time_frame>
    <description>Primary substance use relapse was measured by urine tests (0 = negative, 1 = positive).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Participation in Recovery Behaviors Over Time</measure>
    <time_frame>baseline, discharge, 3-, 6- and 9-month follow-ups</time_frame>
    <description>Recovery behaviors defined as mean number of days doing extracurricular/recovery-goal directed activities using repeated measures over time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recovery Confidence (Self-efficacy) Over Time</measure>
    <time_frame>baseline, discharge, 3-, 6-, and 9-month follow-ups</time_frame>
    <description>Change/improvements in mean recovery confidence score over time (measured by question &quot;How confident are you in your ability to be completely abstinent (clean) from alcohol and drugs in the next 30 days?&quot; (units on scale included 0=not at all, 1=slightly, 2=moderately, 3=considerably, 4-extremely).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Social Support Utilization</measure>
    <time_frame>Baseline, discahrge, 3 month follow-up, 6 month follow-up, 9 month follow-up</time_frame>
    <description>Self-help utilization was measured by the question: &quot;In the past 30 days, how many days did you attend self-help meetings like AA or NA to support your recovery?&quot;</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Addiction</condition>
  <arm_group>
    <arm_group_label>Mobile Continuing Care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Behavioral: 12-week Structured Texting intervention focused on recovery monitoring, feedback for self-management, social support and education</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Continuing Care as Usual</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Continuing care as usual to 12-step facilitation (Anonymous group)</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mobile Continuing Care</intervention_name>
    <description>Behavioral: Mobile Texting 12-week intervention. Delivers daily Recovering monitoring, self-management feedback, and education/social support</description>
    <arm_group_label>Mobile Continuing Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Youth between 12 and 24 years old

          2. Youth in treatment for substance abuse

          3. Youth who complete treatment (minimum 12 weeks)

          4. Youth who have the cognitive capacity to understand study procedures and agree to
             participate

        Exclusion Criteria:

          1. Presence of an adverse (life threatening) medical condition that could interfere with
             study participation.

          2. Presence of psychiatric co-occurring illness or symptoms warranting safety concerns or
             continued treatment, including acute suicide risk; and

          3. Current homelessness (unless residing in recovery home for which contact information
             can be provided).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>24 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rachel Gonzales-Castaneda, MPH, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azusa Pacific University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Azusa Pacific University Psychology Department</name>
      <address>
        <city>Azusa</city>
        <state>California</state>
        <zip>91702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2012</study_first_submitted>
  <study_first_submitted_qc>July 2, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 3, 2012</study_first_posted>
  <results_first_submitted>June 22, 2015</results_first_submitted>
  <results_first_submitted_qc>July 28, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 21, 2015</results_first_posted>
  <last_update_submitted>July 28, 2015</last_update_submitted>
  <last_update_submitted_qc>July 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Continuing Care</keyword>
  <keyword>Youth Substance Abuse</keyword>
  <keyword>Recovery Support</keyword>
  <keyword>Mobile Texting</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Mobile Continuing Care</title>
          <description>Behavioral: 12-week Structured Texting intervention focused on recovery monitoring, feedback for self-management, social support and education
Mobile Continuing Care: Behavioral: Mobile Texting 12-week intervention. Delivers daily recovering monitoring, self-management feedback, and education/social support</description>
        </group>
        <group group_id="P2">
          <title>Standard Continuing Care as Usual</title>
          <description>Continuing care as usual (12-step facilitation) group</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>This study included 80 substance abusing youth who completed treatment and participated in a pilot aftercare project called Project ESQYIR (Educating &amp; Supporting inquisitive Youth in Recovery). Youth were randomized to the mobile aftercare intervention (n=40) or aftercare as usual control (n=40).</population>
      <group_list>
        <group group_id="B1">
          <title>Mobile Continuing Care</title>
          <description>Behavioral: 12-week Structured Texting intervention focused on recovery monitoring, feedback for self-management, social support and education
Mobile Continuing Care: Behavioral: Mobile Texting 12-week intervention. Delivers daily recovering monitoring, self-management feedback, and education/social support</description>
        </group>
        <group group_id="B2">
          <title>Standard Continuing Care as Usual</title>
          <description>Continuing care as usual (12-step facilitation) group</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="40"/>
            <count group_id="B2" value="40"/>
            <count group_id="B3" value="80"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22.1" spread="3.1"/>
                    <measurement group_id="B2" value="19.0" spread="3.1"/>
                    <measurement group_id="B3" value="20.4" spread="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>education</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14.0" spread="2.3"/>
                    <measurement group_id="B2" value="12.0" spread="2.0"/>
                    <measurement group_id="B3" value="12.9" spread="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Primary Substance Use (Defined as Substance Received Treatment for)</title>
        <description>Primary substance use relapse was measured by urine tests (0 = negative, 1 = positive).</description>
        <time_frame>Baseline, discahrge, 3 month follow-up, 6 month follow-up, 9 month follow-up</time_frame>
        <population>An intent to treat model was used. The primary outcome measure is primary substance use measured by urine drug test at baseline, discharge as well as at 3-, 6-, and 9-month follow-ups. Study retention at discharge was 95%, 92.5% at 3 months, 86.2% at 6 months, and 82.5% at 9 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Mobile Continuing Care</title>
            <description>Behavioral: 12-week Structured Texting intervention focused on recovery monitoring, feedback for self-management, social support and education
Mobile Continuing Care: Behavioral: Mobile Texting 12-week intervention. Delivers daily recovering monitoring, self-management feedback, and education/social support</description>
          </group>
          <group group_id="O2">
            <title>Standard Continuing Care as Usual</title>
            <description>Continuing care as usual (12-step facilitation) group</description>
          </group>
        </group_list>
        <measure>
          <title>Primary Substance Use (Defined as Substance Received Treatment for)</title>
          <description>Primary substance use relapse was measured by urine tests (0 = negative, 1 = positive).</description>
          <population>An intent to treat model was used. The primary outcome measure is primary substance use measured by urine drug test at baseline, discharge as well as at 3-, 6-, and 9-month follow-ups. Study retention at discharge was 95%, 92.5% at 3 months, 86.2% at 6 months, and 82.5% at 9 months.</population>
          <units>percentage of positive urines</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline substance use</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.5"/>
                    <measurement group_id="O2" value="41.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>discharge substace use</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.7"/>
                    <measurement group_id="O2" value="62.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-month follow-up substace use</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.4"/>
                    <measurement group_id="O2" value="59.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-month follow-up substace use</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.7"/>
                    <measurement group_id="O2" value="50.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9-month follow-up substace use</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.1"/>
                    <measurement group_id="O2" value="14.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>GEE</method>
            <method_desc>Generalized Estimating Equations regression examined primary relapse (measured by urinalysis) over time by condition, controlling for age and gender.</method_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.75</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.57</ci_lower_limit>
            <ci_upper_limit>0.99</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Participation in Recovery Behaviors Over Time</title>
        <description>Recovery behaviors defined as mean number of days doing extracurricular/recovery-goal directed activities using repeated measures over time.</description>
        <time_frame>baseline, discharge, 3-, 6- and 9-month follow-ups</time_frame>
        <population>Intent to treatment model was used. Mixed modeling used to examine differences in recovery behaviors (measured by mean days doing extracurricular/recovery-goal directed activities) over time between study conditions.</population>
        <group_list>
          <group group_id="O1">
            <title>Mobile Continuing Care</title>
            <description>Behavioral: 12-week Structured Texting intervention focused on recovery monitoring, feedback for self-management, social support and education
Mobile Continuing Care: Behavioral: Mobile Texting 12-week intervention. Delivers daily recovering monitoring, self-management feedback, and education/social support</description>
          </group>
          <group group_id="O2">
            <title>Standard Continuing Care as Usual</title>
            <description>Continuing care as usual (12-step facilitation) group</description>
          </group>
        </group_list>
        <measure>
          <title>Participation in Recovery Behaviors Over Time</title>
          <description>Recovery behaviors defined as mean number of days doing extracurricular/recovery-goal directed activities using repeated measures over time.</description>
          <population>Intent to treatment model was used. Mixed modeling used to examine differences in recovery behaviors (measured by mean days doing extracurricular/recovery-goal directed activities) over time between study conditions.</population>
          <units>days per month</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline recovery behaviors</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.1" spread="9.7"/>
                    <measurement group_id="O2" value="14.5" spread="11.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>discharge recovery behaviors</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.3" spread="8.5"/>
                    <measurement group_id="O2" value="10.3" spread="11.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-month recovery behaviors</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.5" spread="9.5"/>
                    <measurement group_id="O2" value="11.97" spread="11.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-month recovery behaviors</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.5" spread="10.6"/>
                    <measurement group_id="O2" value="13.8" spread="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9-month recovery behaviors</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.4" spread="10.6"/>
                    <measurement group_id="O2" value="12.4" spread="16.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Mixed modeling using a repeated-measures random-effects model was conducted to test for the effects of treatment (dummy coded with 1 = mobile intervention, 0 = control) and time as well as the treatment x time interaction on the primary outcome measures of recovery behaviors mean days over time (baseline, discharge, 3, 6, and 9-month follow-ups).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Mixed Models Analysis</method>
            <method_desc>Analyses controlled for age and gender.</method_desc>
            <param_type>Beta (timexcondition)</param_type>
            <param_value>0.239</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.219</ci_lower_limit>
            <ci_upper_limit>0.248</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Recovery Confidence (Self-efficacy) Over Time</title>
        <description>Change/improvements in mean recovery confidence score over time (measured by question &quot;How confident are you in your ability to be completely abstinent (clean) from alcohol and drugs in the next 30 days?&quot; (units on scale included 0=not at all, 1=slightly, 2=moderately, 3=considerably, 4-extremely).</description>
        <time_frame>baseline, discharge, 3-, 6-, and 9-month follow-ups</time_frame>
        <population>Used an intent to treat design. Examined the effects of the intervention (mobile continuing care) compared to aftercare as usual on change in recovery self-confidence over time.</population>
        <group_list>
          <group group_id="O1">
            <title>Mobile Continuing Care</title>
            <description>Behavioral: 12-week Structured Texting intervention focused on recovery monitoring, feedback for self-management, social support and education
Mobile Continuing Care: Behavioral: Mobile Texting 12-week intervention. Delivers daily recovering monitoring, self-management feedback, and education/social support</description>
          </group>
          <group group_id="O2">
            <title>Standard Continuing Care as Usual</title>
            <description>Continuing care as usual (12-step facilitation) group</description>
          </group>
        </group_list>
        <measure>
          <title>Recovery Confidence (Self-efficacy) Over Time</title>
          <description>Change/improvements in mean recovery confidence score over time (measured by question &quot;How confident are you in your ability to be completely abstinent (clean) from alcohol and drugs in the next 30 days?&quot; (units on scale included 0=not at all, 1=slightly, 2=moderately, 3=considerably, 4-extremely).</description>
          <population>Used an intent to treat design. Examined the effects of the intervention (mobile continuing care) compared to aftercare as usual on change in recovery self-confidence over time.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline confidence rating</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.40" spread="1.3"/>
                    <measurement group_id="O2" value="2.53" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>discharge confidence rating</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.73" spread="1.03"/>
                    <measurement group_id="O2" value="2.57" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-month follow-up confidence rating</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.67" spread="1.3"/>
                    <measurement group_id="O2" value="2.43" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-month follow-up confidence rating</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.20" spread="1.02"/>
                    <measurement group_id="O2" value="2.51" spread="1.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9-month follow-up confidence rating</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.85" spread="1.3"/>
                    <measurement group_id="O2" value="2.73" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Mixed modeling using a repeated-measures random-effects model was conducted to test for the effects of treatment (dummy coded with 1 = mobile intervention, 0 = control) and time as well as the treatment x time interaction on the outcome measure of recovery confidence mean score over time.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Mixed Models Analysis</method>
            <method_desc>A repeated-measures model tested for effects of treatment vs. control on recovery self-confidence over time controlling for age and gender.</method_desc>
            <param_type>Beta (time x condition)</param_type>
            <param_value>0.115</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.106</ci_lower_limit>
            <ci_upper_limit>0.123</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Social Support Utilization</title>
        <description>Self-help utilization was measured by the question: &quot;In the past 30 days, how many days did you attend self-help meetings like AA or NA to support your recovery?”</description>
        <time_frame>Baseline, discahrge, 3 month follow-up, 6 month follow-up, 9 month follow-up</time_frame>
        <population>Intent to treat model was used to assess the effects of the intervention (mobile continuing care) compared to aftercare as usual in terms of improvements in social support service utilization over time (baseline, discharge and follow-ups: 3-, 6- and 9-months post-discharge).</population>
        <group_list>
          <group group_id="O1">
            <title>Mobile Continuing Care</title>
            <description>Behavioral: 12-week Structured Texting intervention focused on recovery monitoring, feedback for self-management, social support and education
Mobile Continuing Care: Behavioral: Mobile Texting 12-week intervention. Delivers daily recovering monitoring, self-management feedback, and education/social support</description>
          </group>
          <group group_id="O2">
            <title>Standard Continuing Care as Usual</title>
            <description>Continuing care as usual (12-step facilitation) group</description>
          </group>
        </group_list>
        <measure>
          <title>Social Support Utilization</title>
          <description>Self-help utilization was measured by the question: &quot;In the past 30 days, how many days did you attend self-help meetings like AA or NA to support your recovery?”</description>
          <population>Intent to treat model was used to assess the effects of the intervention (mobile continuing care) compared to aftercare as usual in terms of improvements in social support service utilization over time (baseline, discharge and follow-ups: 3-, 6- and 9-months post-discharge).</population>
          <units>days per month</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>baseline social support utilization</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.8" spread="10.3"/>
                    <measurement group_id="O2" value="9.8" spread="8.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>discharge social support utilization</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.6" spread="10.1"/>
                    <measurement group_id="O2" value="2.8" spread="6.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-month follow-up social support utilization</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.4" spread="9.5"/>
                    <measurement group_id="O2" value="2.4" spread="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-month upport utilization</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.1" spread="8.5"/>
                    <measurement group_id="O2" value="2.8" spread="7.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9-month upport utilization</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9" spread="7.7"/>
                    <measurement group_id="O2" value="2.8" spread="7.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Mixed modeling using a repeated-measures random-effects model was conducted to test for the effects of treatment (dummy coded with 1 = mobile intervention, 0 = control) and time as well as the treatment x time interaction on the outcome measure of self-help utilization (mean days in past month) over the study period (baseline, discharge, and 3-, 6-, and 9-month follow-ups).</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Mixed Models Analysis</method>
            <method_desc>Analyses controlled for age and gender.</method_desc>
            <param_type>Beta effect (timexcondition)</param_type>
            <param_value>0.217</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.2</ci_lower_limit>
            <ci_upper_limit>0.233</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>During the 9-month study period.</time_frame>
      <desc>Serious and non-serious adverse events were not observed during the study period.</desc>
      <group_list>
        <group group_id="E1">
          <title>Mobile Continuing Care</title>
          <description>Behavioral: 12-week Structured Texting intervention focused on recovery monitoring, feedback for self-management, social support and education
Mobile Continuing Care: Behavioral: Mobile Texting 12-week intervention. Delivers daily recovering monitoring, self-management feedback, and education/social support</description>
        </group>
        <group group_id="E2">
          <title>Standard Continuing Care as Usual</title>
          <description>Continuing care as usual (12-step facilitation) group</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Pilot study limiting number of participants recruited.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Rachel Gonzales Castaneda</name_or_title>
      <organization>Azusa Pacific University</organization>
      <phone>6268156000 ext 2744</phone>
      <email>rcastaneda@apu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

